Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2014 1
2017 1
2018 2
2020 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
The PLIANT trial gives trustworthy data.
Glimelius B, Kowalski J, Näsström J. Glimelius B, et al. Among authors: nasstrom j. Acta Oncol. 2018 Jun;57(6):864-866. doi: 10.1080/0284186X.2018.1433876. Epub 2018 Feb 2. Acta Oncol. 2018. PMID: 29392966 No abstract available.
Reply to a Comment Paper on the Published Paper by Canta, A. et al: "Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity"-Antioxidants 2020, 9, 594.
Canta A, Chiorazzi A, Pozzi E, Fumagalli G, Monza L, Meregalli C, Carozzi VA, Rodriguez-Menendez V, Oggioni N, Näsström J, Marmiroli P, Cavaletti G. Canta A, et al. Among authors: nasstrom j. Antioxidants (Basel). 2020 Sep 1;9(9):807. doi: 10.3390/antiox9090807. Antioxidants (Basel). 2020. PMID: 32882796 Free PMC article.
Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity.
Canta A, Chiorazzi A, Pozzi E, Fumagalli G, Monza L, Meregalli C, Carozzi VA, Rodriguez-Menendez V, Oggioni N, Näsström J, Marmiroli P, Cavaletti G. Canta A, et al. Among authors: nasstrom j. Antioxidants (Basel). 2020 Jul 7;9(7):594. doi: 10.3390/antiox9070594. Antioxidants (Basel). 2020. PMID: 32645985 Free PMC article.
Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx®): a placebo-controlled randomised phase II study (PLIANT).
Glimelius B, Manojlovic N, Pfeiffer P, Mosidze B, Kurteva G, Karlberg M, Mahalingam D, Buhl Jensen P, Kowalski J, Bengtson M, Nittve M, Näsström J. Glimelius B, et al. Among authors: nasstrom j. Acta Oncol. 2018 Mar;57(3):393-402. doi: 10.1080/0284186X.2017.1398836. Epub 2017 Nov 15. Acta Oncol. 2018. PMID: 29140155 Clinical Trial.